Centerspace (CSR) - Q2 2026 10-Q Summary
Business Context and Reporting Period
Company: Centerspace (North Dakota REIT)
Reporting Period: Quarter and six months ended June 30, 2026
Portfolio: 60 apartment communities totaling 12,090 homes as of June 30, 2026.
Strategy: Focused on ownership, management, and redevelopment of apartment communities in the Midwest and Mountain West. The company is actively executing a disposition strategy, with 13 communities classified as "held for sale" as of the reporting date.
Key Financial Metrics
| Metric (in thousands) | Q2 2026 | Q2 2025 | 6M 2026 | 6M 2025 |
|---|---|---|---|---|
| Revenue | $65,782 | $68,549 | $130,851 | $135,642 |
| Net Operating Income (NOI) | $41,135 | $42,018 | $80,630 | $82,380 |
| Net Loss | $(1,130) | $(16,785) | $(16,103) | $(20,966) |
| Net Loss to Common Shareholders | $(1,020) | $(14,515) | $(13,909) | $(18,249) |
| FFO (Diluted) | $23,607 | $24,697 | $44,765 | $48,029 |
| Core FFO (Diluted) | $25,038 | $25,457 | $47,136 | $49,596 |
| Cash from Operations (6M) | $44,128 | $50,694 | ||
| Total Debt (Net) | ||||
| Liquidity (Cash + Credit Avail.) | $242.6 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 4.0% QoQ and 3.5% YoY (6M), primarily driven by the sale of 12 communities in the prior year compared to only one disposition in the current period.
- Improved Net Loss: Net loss attributable to common shareholders improved significantly (93% reduction in Q2, 24% reduction in 6M) due to the absence of the $14.5 million impairment charge recorded in Q2 2025.
- Impairment Charges: Recorded a $9.7 million impairment on one Denver apartment community in the first half of 2026, compared to $14.5 million in the same period of 2025.
- Dispositions: Sold one community (Civic Lofts, Denver) for $30.0 million in Q2 2026, recognizing a $271,000 gain. No dispositions occurred in Q2 2025.
- Same-Store Performance: Same-store NOI increased 0.3% in Q2 but decreased 1.3% for the six-month period, with occupancy remaining stable at 96.0% (Q2) and 95.7% (6M).
Guidance, Outlook, and Risks
- Disposition Strategy: The Board approved the sale of 13 apartment communities (1,634 homes) classified as held for sale, expected to close in Q3 2026. Subsequent events note the completion of sales totaling $139.8 million in July 2026.
- Capital Allocation: Proceeds from dispositions are intended to pay down the line of credit and fund working capital. The company repurchased 45,310 shares in Q2 2026 at an average price of $55.54, with $94.0 million remaining under the $100 million repurchase program.
- Debt Profile: Total debt is $989.6 million. The unsecured credit facility was expanded to $400.0 million in May 2025; $176.0 million is currently drawn with $224.0 million available. Weighted average interest rate on mortgages is 3.94%.
- Risks: Key risks include the ability to complete proposed dispositions on favorable terms, interest rate volatility affecting variable debt, and potential inability to reinvest proceeds successfully. The company faces standard REIT risks regarding occupancy, rental rates, and inflationary pressure on operating costs.
Investor Verification Checklist
- Disposition Timeline: Verify the closing dates and final sale prices for the 13 communities currently held for sale, as these will significantly impact Q3 liquidity and asset base.
- Impairment Specifics: Review the details of the $9.7 million impairment on the Denver property to assess if further write-downs are likely for other held-for-sale assets.
- Debt Maturity Wall: Confirm the schedule for mortgage maturities, particularly the $290 million due in 2028, and the company's refinancing strategy given current interest rate environments.
- Core FFO Sustainability: Monitor if Core FFO per share can stabilize or grow given the reduction in the asset base from dispositions and the impact of increased G&A expenses ($1.3 million increase in Q2).
- Share Repurchase Activity: Track the utilization of the remaining $94 million repurchase authorization to gauge management's confidence in the stock price relative to intrinsic value.